$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000182252323000032 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$15.87M	$15.27M
YoY Change	-19.44%	-15.81%
Cost Of Revenue	$3.472M	$3.570M
YoY Change	-10.79%	-6.66%
Gross Profit	$12.40M	$10.48M
YoY Change	-21.57%	-26.8%
Gross Profit Margin	78.13%	68.62%
Selling, General & Admin	$1.592M	$1.580M
YoY Change	-21.53%	6.05%
% of Gross Profit	12.84%	15.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.592M	$5.151M
YoY Change	-21.53%	-3.07%
Operating Profit	$10.81M	$5.329M
YoY Change	-21.58%	-40.8%
Interest Expense	-$7.361M	$1.533M
YoY Change	262.37%	-6.76%
% of Operating Profit	-68.1%	28.77%
Other Income/Expense, Net	-$11.98M	-$1.050M
YoY Change	47.26%	93.74%
Pretax Income	-$8.535M	$8.643M
YoY Change	-336.13%	-25.8%
Income Tax	$653.4K	$700.0K
% Of Pretax Income		8.1%
Net Earnings	-$9.188M	$7.980M
YoY Change	-412.74%	-30.49%
Net Earnings / Revenue	-57.89%	52.25%
Basic Earnings Per Share		$0.39
Diluted Earnings Per Share	-$0.45	$0.39
COMMON SHARES
Basic Shares Outstanding	20.46M shares	20.46M shares
Diluted Shares Outstanding		20.34M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.6M	$73.20M
YoY Change	-13.35%	101.54%
Cash & Equivalents	$121.6M	$73.20M
Short-Term Investments
Other Short-Term Assets	$688.5K	$500.0K
YoY Change	49.39%	-11.34%
Inventory
Prepaid Expenses
Receivables	$1.837M
Other Receivables	$0.00
Total Short-Term Assets	$124.2M	$73.70M
YoY Change	-11.84%	99.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$342.4M	$371.4M
YoY Change	-9.49%	-14.51%
TOTAL ASSETS
Total Short-Term Assets	$124.2M	$73.70M
Total Long-Term Assets	$342.4M	$371.4M
Total Assets	$466.6M	$445.1M
YoY Change	-10.13%	-5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$714.7K	$800.0K
YoY Change	-14.58%	-29.29%
Accrued Expenses	$5.852M	$7.600M
YoY Change	-41.32%	-44.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$58.40M	$18.20M
YoY Change	-28.98%	-30.67%
LONG-TERM LIABILITIES
Long-Term Debt	$88.01M	$87.90M
YoY Change	-9.39%	-9.35%
Other Long-Term Liabilities	$115.5K	$200.0K
YoY Change	-84.69%	-70.96%
Total Long-Term Liabilities	$88.13M	$88.10M
YoY Change	-9.97%	-9.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.40M	$18.20M
Total Long-Term Liabilities	$88.13M	$88.10M
Total Liabilities	$146.5M	$106.3M
YoY Change	-18.65%	-14.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.96M	-$10.94M
YoY Change	200.72%	634.93%
Common Stock	$204.6K	$204.6K
YoY Change	0.46%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$320.1M	$338.8M
YoY Change
Total Liabilities & Shareholders Equity	$466.6M	$445.1M
YoY Change	-10.13%	-5.56%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$9.188M	$7.980M
YoY Change	-412.74%	-30.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$6.239M	$5.460M
YoY Change	61.37%	-55.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$10.01M	-$4.520M
YoY Change	-80.81%	-76.7%
Cash From Investing Activities	$10.01M	-$4.520M
YoY Change	-80.81%	-76.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.17M	-9.820M
YoY Change	-32.99%	368.54%
NET CHANGE
Cash From Operating Activities	6.239M	5.460M
Cash From Investing Activities	10.01M	-4.520M
Cash From Financing Activities	32.17M	-9.820M
Net Change In Cash	48.42M	-8.880M
YoY Change	-53.46%	-4.14%
FREE CASH FLOW
Cash From Operating Activities	$6.239M	$5.460M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	203640	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348817914	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9962186	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	519176899	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	60072643	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	5091207	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54981436	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1307969	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11873516	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3372813	usd
	us-gaap	Professional Fees ProfessionalFees	1017525	usd
	us-gaap	Operating Expenses OperatingExpenses	17485336	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3040135	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1561890	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	33344075	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	349763	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19687730	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19780003	shares
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	168750	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7979875	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11480519	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30140482	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33163062	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	340318237	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31861647	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	5607675	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y1M6D
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2023Q1	afcg	Severance Costs Period To Receive Base Salary SeveranceCostsPeriodToReceiveBaseSalary	P12M
CY2023Q1	afcg	Severance Cobra Premiums Paid Period SeveranceCOBRAPremiumsPaidPeriod	P12M
CY2023Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension	P1Y
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20457697	shares
CY2023Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	72573622	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	70010878	usd
CY2023Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	308011076	usd
CY2023Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14274997	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	295776137	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73204542	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	4584002	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5257475	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1000000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	0	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	526236	usd
CY2023Q3	us-gaap	Assets Assets	445101795	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	550950	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1036667	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	18146	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2022Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	754128	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	3891734	usd
CY2022Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1843652	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	836642	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	97131777	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	60000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	180117530	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20364000	shares
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	294014	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.48
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9819695	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	7979875	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	338772431	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338200365	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9023889	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	114704	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.56
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	11403840	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	693441	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.52
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31113361	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Net Income Loss NetIncomeLoss	30140482	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	338772431	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73346205	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1221562	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.67
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33382866	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	347415637	usd
	us-gaap	Net Income Loss NetIncomeLoss	30140482	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	149637	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3040135	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1239800	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1152810	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1561890	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	4435186	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	9710278	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	693441	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1221482	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	9404473	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	5051007	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-673473	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	29742	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	79474	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-217685	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	4149994	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	-894159	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1130083	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1403993	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-316867	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1001691	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-499024	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	27209	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-13504	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-379934	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14990354	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27456066	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	51757225	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	127248748	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	21312827	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10600000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15900000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	49953251	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	32227904	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18508853	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68520844	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75057650	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1711365	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	225000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	21000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	32705006	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	30207932	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	7737500	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	81000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100667506	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67168299	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-72926425	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73204542	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36319623	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	1500000	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	450000	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	7398475	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	9819695	usd
	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	11403840	usd
	us-gaap	Interest Paid Net InterestPaidNet	2951250	usd
	us-gaap	Interest Paid Net InterestPaidNet	2972743	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1078959	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	41287	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q3	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2023Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2023Q3	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	25477552	usd
CY2023Q3	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	82005077	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	2	loan
CY2022	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2023Q3	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	94200000	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	104300000	usd
CY2023Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	73000000	usd
	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	1900000	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	33000000	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	70010878	usd
CY2023Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	72573622	usd
CY2023Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	73005930	usd
	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y7M6D
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P1Y2M12D
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	180595	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	1740561	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-1409934	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
	afcg	Loans Held For Investment Realized Gain Loss On Loans At Fair Value Net LoansHeldForInvestmentRealizedGainLossOnLoansAtFairValueNet	-1213416	usd
	afcg	Loans Held For Investment At Fair Value Realized Gain Loss On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueRealizedGainLossOnLoansAtFairValueNet	-1213416	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-1152810	usd
	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-1152810	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	1881840	usd
	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	1881840	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	1308253	usd
	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	1308253	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	33032561	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	33032561	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	2993521	usd
	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	2993521	usd
CY2023Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	73005930	usd
CY2023Q3	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	432308	usd
CY2023Q3	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-2562744	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	70010878	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	70010878	usd
CY2023Q3	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	72573622	usd
CY2023Q3	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	73005930	usd
	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2022	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2023Q3	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	335100000	usd
CY2022Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	338900000	usd
	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	59100000	usd
	afcg	Receivable With Imputed Interest Loan Repayments And Amortization Payments ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments	16700000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	22600000	usd
CY2023Q3	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.84
CY2022Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.73
CY2023Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	322737668	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	14726592	usd
CY2023Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	308011076	usd
	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y6M
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	59088860	usd
	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	7713475	usd
	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	51375385	usd
	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	3126933	usd
	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	3126933	usd
	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	12676917	usd
	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	12676917	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	22606578	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	1267367	usd
	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	21339211	usd
	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	6410952	usd
	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	6410952	usd
	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	4063178	usd
	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	4063178	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	322737668	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	14726592	usd
CY2023Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	308011076	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	322737668	usd
CY2023Q3	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	14726592	usd
CY2023Q3	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	308011076	usd
CY2023Q3	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2022Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2023Q3	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2023Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	200000	usd
	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	180595	usd
CY2023Q3	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2041744	usd
CY2023Q3	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	185794806	usd
CY2023Q3	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	16773699	usd
CY2023Q3	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	310051134	usd
CY2023Q3	afcg	Interest Receivables InterestReceivables	3733028	usd
CY2022Q4	afcg	Interest Receivables InterestReceivables	3722134	usd
CY2023Q3	afcg	Payment In Kind Receivable PaymentInKindReceivable	825974	usd
CY2022Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	1409678	usd
CY2023Q3	afcg	Unused Fees Receivable UnusedFeesReceivable	25000	usd
CY2022Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	125663	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	4584002	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5257475	usd
	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	1	loan
CY2022	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	3	loan
CY2023Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	600000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4200000	usd
CY2022Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3000000	usd
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1130541	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5186615	usd
CY2023Q3	afcg	New Reserves Interest NewReservesInterest	0	usd
CY2022Q3	afcg	New Reserves Interest NewReservesInterest	3970958	usd
	afcg	New Reserves Interest NewReservesInterest	1526065	usd
	afcg	New Reserves Interest NewReservesInterest	9970958	usd
CY2023Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	579591	usd
CY2022Q3	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3031143	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4176059	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	8626799	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	550950	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6126430	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	550950	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6126430	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1304250	usd
CY2023Q3	afcg	Line Of Credit Facility Commitment Fee Reversal Amount LineOfCreditFacilityCommitmentFeeReversalAmount	-26667	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	255345	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1532928	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1437500	usd
CY2022Q3	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	0	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	206588	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1644088	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4033417	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	47915	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	695531	usd
	us-gaap	Interest Expense InterestExpense	4776863	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4316319	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	60417	usd
	us-gaap	Interest Expense InterestExpense	5091207	usd
CY2022Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	447101864	usd
CY2022Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	401476418	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	45625446	usd
CY2023Q1	afcg	Severance Cobra Premiums Paid Percentage SeveranceCOBRAPremiumsPaidPercentage	1
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches	1	tranche
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.50
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	61500000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3291832	shares
CY2022Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	67500000	usd
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	63000000.0	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	213538	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	293420	shares
CY2023Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2161094	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2081212	shares
CY2023Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2023Q3	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	88749	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2273272	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	104320	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.23
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.20
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316106	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	24023	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.20
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2286572	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	111420	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.23
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.20
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	742000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.46
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5511	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	54153	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.12
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2286572	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	7979875	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	11480519	usd
	us-gaap	Net Income Loss NetIncomeLoss	30140482	usd
	us-gaap	Net Income Loss NetIncomeLoss	32994312	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
CY2023Q3	us-gaap	Dividends Dividends	65991	usd
CY2022Q3	us-gaap	Dividends Dividends	36165	usd
	us-gaap	Dividends Dividends	205268	usd
	us-gaap	Dividends Dividends	99827	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7913884	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7913884	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11444354	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11444354	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29927714	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	29927714	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	32886985	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	32886985	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20324125	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20019760	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20315162	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19687730	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18755	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	92273	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	75223	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	92273	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20342880	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20112033	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20390385	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19780003	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2288419	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2247328	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1406700	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1406700	shares
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2022Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	70010878	usd
CY2023Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	70010878	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	99226051	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	200000	usd
CY2023Q3	afcg	Incentive Compensation IncentiveCompensation	2600000	usd
	afcg	Incentive Compensation IncentiveCompensation	7900000	usd
CY2022Q3	afcg	Incentive Compensation IncentiveCompensation	2900000	usd
	afcg	Incentive Compensation IncentiveCompensation	9300000	usd
CY2023Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4392852	usd
CY2022Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4734978	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	13393793	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	14664362	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1000000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	0	usd
	us-gaap	Loan Processing Fee LoanProcessingFee	1100000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.67
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33382865	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.52
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31113361	usd

Files In Submission

Name	View Source	Status
afcg-20230930_cal.xml	Edgar Link	unprocessable
0001822523-23-000032-index-headers.html	Edgar Link	pending
0001822523-23-000032-index.html	Edgar Link	pending
0001822523-23-000032.txt	Edgar Link	pending
0001822523-23-000032-xbrl.zip	Edgar Link	pending
afcg-20230930.htm	Edgar Link	pending
afcg-20230930.xsd	Edgar Link	pending
afcg-20230930xex311.htm	Edgar Link	pending
afcg-20230930xex312.htm	Edgar Link	pending
afcg-20230930xex321.htm	Edgar Link	pending
afcg-20230930xex322.htm	Edgar Link	pending
afcg-20230930_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
afcg-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20230930_lab.xml	Edgar Link	unprocessable
afcg-20230930_pre.xml	Edgar Link	unprocessable
afcg-20230930_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2023 Q4 Form 10-Q Financial Statement

#000182252323000032 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2023 Q4 Form 10-Q Financial Statement

#000182252323000032 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg